You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香港醫思醫療集團(02138.HK)擬斥資8524.9萬港元收購婦產科業務
格隆匯 10-21 06:30

格隆匯 10 月 21日丨香港醫思醫療集團(02138.HK)發佈公告,2020年10月20日,集團與一名在香港醫務委員會在專科醫生名單的婦產科註冊專科醫生訂立有條件的買賣協議,據此,集團有條件同意收購且專科醫生有條件同意出售由專科醫生全資持有的目標公司已發行全部股本的51%,總代價為現金8524.9萬港元。惟須受協議的條款所規限,專科醫生向集團保證截至2028年3月31日共八個財年的目標公司的累計經審計的税後溢利應不少於約1.66億港元。完成時,目標公司的財務資料將綜合入賬集團綜合財務報表。

目標公司主要在婦產科領域提供醫療服務。根據截止2020年3月31日全年的未經審計財務資料,2020年3月31日全年的未經審計税後溢利及2020年3月31日的未經審計資產淨值分別為約16.5百萬港元及2870萬港元。截止該公告,目標公司於香港運營4間診所,並有8名婦產科註冊專科醫生。目標公司同時提供香港以外地區的體外人工受孕的轉介服務。

公告表示,為了優化醫療服務組合,集團持續積極邀請在香港醫務委員會專科醫生名冊上的不同專科的註冊專科醫生進駐。近年,市場對於婦產科的醫療及相關服務求渴若切,收購婦產科業務不僅有助提升為集團女性客户及人才提供健康與養生服務的協同性及促進集團醫療旅遊的策略,亦有助於拓本集團於,其中包括,投資及/或營運體外人工受孕實驗室及提供生殖醫學服務的能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account